undamentalytics Newsletter
Sign in

Eyepoint, Inc. cash flow statement

In fiscal 2025, Eyepoint, Inc.'s operations generated −$240m of cash; it spent $3.3m on capital projects, leaving free cash flow of −$243m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Jun 20102011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations10−3−9−9−1110−16−20−22−57−14−50−652−126−240−267
Depreciation and amortisation00000000000000223
Stock-based pay1211122235671412372835
Capital spending00000000000023434
Free cash flow10−3−9−9−1110−16−21−22−57−15−50−67−2−130−243−271
Free cash flow after stock pay8−5−11−10−128−19−23−25−61−20−58−81−14−167−271−306
Shares issued—10—5180178422350—0226163173—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: EYPT vs TXMDCPHI vs EYPTEYPT vs NTRB

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Eyepoint, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Eyepoint, Inc.